Increased cutaneous miR-let-7d expression correlates with small nerve fiber pathology in patients with fibromyalgia

Mathias Leinders1, Kathrin Doppler1, Thomas Klein1

  • 1Department of Neurology, University of Würzburg, Würzburg, Germany.

Pain
|July 19, 2016
PubMed

Insights

MicroRNAs (miRNAs) may play a role in fibromyalgia syndrome (FMS) subgroups with small nerve fiber loss. This study links specific miRNA expression to nerve fiber damage in FMS patients.

Area of Science:

  • Neurology
  • Molecular Biology
  • Genetics

Background:

  • Fibromyalgia syndrome (FMS) is a complex chronic pain condition with likely distinct subgroups.
  • Small nerve fiber impairment is increasingly recognized in certain FMS patient groups.
  • MicroRNAs (miRNAs) are crucial regulators of nerve regeneration and degeneration.

Purpose of the Study:

  • To investigate the relationship between systemic and cutaneous miRNA expression and small nerve fiber pathology in fibromyalgia syndrome.
  • To identify specific miRNAs associated with small nerve fiber impairment in FMS subgroups.

Main Methods:

  • Confirmed small fiber dysfunction and reduced intraepidermal nerve fiber density in FMS subgroups.
  • Analyzed systemic miRNA expression in white blood cells from FMS patients.
  • Examined cutaneous miRNA and target gene expression in FMS patients with small nerve fiber impairment.

Main Results:

  • Identified 51 aberrantly expressed miRNAs in white blood cells of FMS patients.
  • Found a correlation between miR-let-7d expression and reduced small nerve fiber density in FMS.
  • Demonstrated aberrant expression of miR-let-7d and its target, IGF-1R, in the skin of FMS patients with nerve fiber loss.

Conclusions:

  • Provides further evidence for small nerve fiber pathology in specific fibromyalgia syndrome subgroups.
  • Suggests a potential role for miR-let-7d in the pathomechanism leading to small fiber loss in FMS.
  • Highlights miRNAs as potential biomarkers or therapeutic targets in FMS subgroups.